Atossa Therapeutics
ATOS
#9802
Rank
NZ$75.62 M
Marketcap
NZ$8.78
Share price
-6.92%
Change (1 day)
600.72%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.42

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.43. In 2024 the company made an earnings per share (EPS) of NZ-$0.34 an increase over its 2023 EPS that were of NZ-$0.41.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.4221.73%
2024NZ-$0.34-16.67%
2023NZ-$0.4114.29%
2022NZ-$0.3616.67%
2021NZ-$0.31-90.86%
2020NZ-$3.39-2.96%
2019NZ-$3.49-63.09%
2018NZ-$9.45-49.63%
2017NZ-$18.77-57.87%
2016NZ-$44.55-74.01%
2015NZ-$171.38-9.18%
2014NZ-$188.70-12.86%
2013NZ-$216.5470.73%
2012NZ-$126.8334.08%
2011NZ-$94.60263.47%
2010NZ-$26.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.14-4,554.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$14.85-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.62-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.51 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA